Grifols SA (EUR)
GRF
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range21.35 | 21.72
52-Wk Range- | -
Last Close20.82
Mkt Cap (m)12,236.53
Dividend yield0.78
ISINES0171996087
Volume209,174.00
Exchange VenueXMAD

Company Profile

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.

Key Information
Price/Earning20.82
Price/Book2.67
Price/Sales2.65
P/CF13.21
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 23/04/2015
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.grifols.com

Financials

Income Statement
EUR201520162017201820192020
Revenue (m)3,934.564,049.834,318.074,486.725,098.69-
Operating Income (m)970.37939.411,003.34994.121,122.39-
Net Income (m)532.15545.46662.70596.64625.15-
Basic EPS0.780.800.970.870.91-
Avg. Diluted Shares Outstanding (m)685.66684.17684.24684.71685.12-
Balance Sheet
EUR201520162017201820192020
Current Assets (m)3,089.473,122.512,945.323,483.255,362.18-
Non Current Assets (m)6,512.247,007.267,974.958,993.8010,180.43-
Total Assets (m)9,601.7210,129.7710,920.2612,477.0515,542.61-
Current Liabilities (m)1,053.011,071.76977.991,257.321,366.56-
Total Liabilities (m)------
Total Equity (m)3,296.203,721.483,629.084,225.554,822.12-
Cash Flows
EUR201520162017201820192020
Operating Cash Flows (m)742.78553.28841.75737.43568.93-
Capital Expenditure (m)-567.02-292.69-322.97-307.72-412.31-
Figures are quoted in EUR unless stated otherwise
0.79 (3.79%)
21.61
Last Price